NK-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome.

摘要

The invention relates to the use of a NK-1 receptor antagonist, in particular a substance P receptor antagonist, for the manufacture of a medicament for the treatment of symptoms of irritable bowel syndrome.